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Abstract
 
Cell surface proteins major histocompatibility complex (MHC) class I–related chain A (MICA)
and UL16-binding proteins (ULBP) 1, 2, and 3 are up-regulated upon infection or tumor trans-
formation and can activate human natural killer (NK) cells. Patches of cross-linked raft resident
ganglioside GM1 colocalized with ULBP1, 2, 3, or MICA, but not CD45. Thus, ULBPs and
MICA are expressed in lipid rafts at the cell surface. Western blotting revealed that glycosylphos-
phatidylinositol (GPI)-anchored ULBP3 but not transmembrane MICA, MHC class I protein,
or transferrin receptor, accumulated in detergent-resistant membranes containing GM1. Thus,
MICA may have a weaker association with lipid rafts than ULBP3, yet both proteins accumulate
at an activating human NK cell immune synapse. Target cell lipid rafts marked by green fluorescent
protein–tagged GPI also accumulate with ULBP3 at some synapses. Electron microscopy reveals
constitutive clusters of ULBP at the cell surface. Regarding a specific molecular basis for the
organization of these proteins, ULBP1, 2, and 3 and MICA are lipid modified. ULBP1, 2, and 3
are GPI anchored, and we demonstrate here that MICA is S-acylated. Finally, expression of a
truncated form of MICA that lacks the putative site for S-acylation and the cytoplasmic tail can
be expressed at the cell surface, but is unable to activate NK cells.
Key words: immunological synapse • natural killer cell • fluorescence imaging • lipid rafts • 
intercellular communication
 
Introduction
 
NK cell activation can be triggered by an absence of in-
hibitory receptor ligation (i.e., by detection of missing
self) and also by ligation of specific activating receptors.
NKG2D is a C-type lectin–activating receptor that recog-
nizes cell surface MHC class I–like proteins up-regulated
upon cell stress, including viral or bacterial infection and
tumor transformation (for review see references 1, 2).
Human ligands for NKG2D, UL16-binding protein
(ULBP) 1, 2, and 3, and MHC class I–related chain A
(MICA; references 3–5) have Ig domains similar to the
 

 
1/
 

 
2 and the 
 

 
1/
 

 
2/
 

 
3 domains, respectively, of MHC
class I protein, but do not associate with 
 

 
2
 
-microglobulin
nor present peptide (for review of crystal structures see
reference 6).
NKG2D is expressed in various immune cells including
NK, NKT, CD8
 

 
 
 

 
 T cells, 
 

 
 T cells, and macrophages.
Its function can be regulated by noncovalent association with
either DNAX-activating protein (DAP) 10 or DAP12 (7,
8). In NK cells, NKG2D-mediated cytotoxicity can be
triggered by signaling from immunoreceptor tyrosine-
based activation motifs in DAP12 or via a Syk-independent
pathway activated by DAP10 (9, 10). Activation of NK
cells via NKG2D can overcome inhibitory signaling from
self recognition (5, 11, 12). In T cells, NKG2D is thought to
associate principally with DAP10 to mediate costimulatory
functions (8, 13, 14).
Lipid rafts are critical in facilitating numerous cellular
processes, including immune cell signaling (for review see
reference 15). Clearly, NK cell lipid rafts play an important
role in NK cell activation and cytotoxicity (16), for example,
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by facilitating the function of 2B4 (17). However, the role
of target cell lipid rafts in controlling NK cell activation has
not yet been addressed. Here, we investigate the organiza-
tion of human NKG2D ligands at target cell surfaces and
the activating NK cell immune synapse.
 
Materials and Methods
 
Cells and Antibodies.
 
Daudi, a Burkitt’s lymphoma B cell
line that lacks expression of 
 

 
2
 
-microglobulin, was transduced
with amphotropic retroviruses encoding 
 

 
2
 
-microglobulin
(Daudi/Class I
 

 
) and further transduced to express ULBP1, 2,
or 3 (Daudi/Class I
 

 
/ULBP1, 2, or 3) or MICA (Daudi/Class
I
 

 
/MICA) as described previously (5). Transfectants of Na-
malwa (American Type Culture Collection), expressing GPI–
green fluorescent protein (GFP) were created by electropora-
tion of pcDNA3.1/Hygro (Invitrogen) encoding the Acrosin
signal sequence–enhanced GFP-Thy1GPI (a gift from G. Kon-
doh, Osaka University, Osaka, Japan; reference 18) as a KpnI/
NotI fragment and selection by flow cytometry. Human pe-
ripheral blood NK cell lines and clones were cultured as de-
scribed previously (19).
For imaging, 15–30 
 

 
g/ml mouse anti–human ULBP1
(M295), ULBP2 (M311), ULBP3 (M551), and MICA (M673)
mAb that have been described previously (5) were used. 5 
 

 
g/ml
mouse anti–human CD45 mAb (HI30; BD Biosciences) and 10
 

 
g/ml mouse anti–human transferrin receptor (TfR) mAb
(H68.4; Zymed Laboratories) were used. Alexa Fluor 488 or 633
goat anti–mouse IgG (Molecular Probes) were used at 4 
 

 
g/ml.
 
Site-directed Mutagenesis.
 
The MICA gene (GenBank/
EMBL/DDBJ accession no. AAD52060 with the exception of
one substitution, Val 256 Ile; reference 5) was subcloned as a
BamHI/NotI fragment into pcDNA3.1/Neo (Invitrogen). In
vitro site-directed mutagenesis was performed (QuickChange
Kit; Stratagene) according to the manufacturer’s instructions us-
ing the following primers: forward, 5
 

 
-CTATGTCCGTTGAT-
GTAAGAAGA-3
 

 
 and reverse, 5
 

 
-TCTTCTTACAACTACG-
GACATAG-3
 

 
. Constructs encoding the correct mutation,
verified by sequencing the full insert, were transfected into
Daudi/Class I
 

 
 cells by electroporation. Cells were selected for
MICA expression by flow cytometry.
 
Patching of GM1 Ganglioside with Cholera Toxin 
 

 
 Subunit
(CT-B).
 
For cross-linking of GM1, 10
 
6
 
 cells were first incu-
bated with 10 
 

 
g/ml CT-B (Sigma-Aldrich) on ice for 30 min
and washed in 1% BSA/5% horse serum/PBS before incubation
with anti–CT-B rabbit antiserum (Sigma-Aldrich) in 1% BSA/5%
horse serum/PBS for 30 min on ice. Patching was induced by in-
cubation with Alexa Fluor 488 goat anti–rabbit IgG or Alexa
Fluor 350 goat anti–rabbit IgG (4 
 

 
g/ml; Molecular Probes) for
20 min at 37
 
	
 
C. Immediately after patching, cells were fixed in
2% paraformaldehyde for 15 min at room temperature (RT). Af-
ter washing, cells were incubated with the primary mAb for 45
min at 4
 
	
 
C, washed in PBS, and incubated for 45 min at 4
 
	
 
C
with 3 
 

 
g/ml Cy5 goat anti–mouse IgG (Jackson ImmunoRe-
search Laboratories) or 4 
 

 
g/ml Alexa Fluor 488 goat anti–mouse
IgG. As a positive control, cells that had been GM1 patched were
stained with an additional secondary mAb, 4 
 

 
g/ml Alexa Fluor
568 goat anti–rabbit IgG for 45 min at 4
 
	
 
C.
 
Laser Scanning Confocal Microscopy and Image Analysis.
 
Cells
were imaged (TCS SP2; Leica) as described previously (19), ex-
cept that here, for imaging immune synapses, cells were fixed in
4% paraformaldehyde for 15 min at RT and cells (10
 
6
 
 of each)
were coincubated in 50 
 

 
l of prewarmed culture medium to fa-
cilitate rapid conjugation.
To quantify colocalization between GM1 and proteins, images
were first corrected for background; a binary mask, outlining the
plasma membrane, was applied to both images; and the correlation
coefficient was calculated on a pixel-by-pixel basis according to
where 
 
g
 
i
 
 and 
 
r
 
i
 
 are the intensities of the green and red channels in
pixel i, and 
 
g
 
 and 
 
r
 
 are the average intensities of the green and red
channels within the region of interest. Appropriate code was writ-
ten in Matlab (The Mathworks Inc.). The correlation coefficient
theoretically ranges from 
 


 
1 to 1, where 1 indicates perfect over-
lap, 0 indicates random distribution, and 
 


 
1 indicates avoidance.
 
Preparation of Detergent-resistant Membranes (DRMs) and Western
Blotting.
 
To prepare DRMs, 5 
 

 
 10
 
7
 
 cells were washed in cold
PBS and lysed for 30 min on ice in 1 ml MNE (25 mM Mes, pH
6.5, 150 mM NaCl, and 1 mM EDTA) containing 1% Triton
X-100, phosphatase inhibitors (5 mM NaF and 0.1 mM Na
 
3
 
VO
 
4
 
),
and protease inhibitors. Lysates were sheared with a cold 23-gauge
needle and mixed with an equal volume of 80% (wt/vol) sucrose/
MNE. This was overlaid with 2 ml 30% (wt/vol) sucrose/MNE
followed by 1 ml 5% (wt/vol) sucrose/MNE. Equilibrium ultra-
centrifugation at 200,000 
 
g
 
 was performed in a precooled SW50.1
swing-out rotor (Beckman Coulter) for 18 h at 4
 
	
 
C.
For Western blotting, equal volumes from 10 fractions were
mixed with 5
 

 
 Laemmli sample buffer and separated by 10 or
15% (for the detection of GM1 ganglioside) of reducing SDS-
PAGE. Proteins were transferred onto 0.2 
 

 
m nitrocellulose
(Optitran; Schleicher and Schuell) or polyvinyldifluoride (Hy-
bond P; Amersham Biosciences) and probed with the indicated
mAb followed by 16 ng/ml horseradish peroxidase (HRP) rabbit
anti–mouse IgG (H 
 
 
 
L) (Immunopure
 
®
 
 antibody; Pierce
Chemical Co.) where needed. For Western blotting, HRP-con-
jugated CT-B (Sigma-Aldrich) was used at 84 ng/ml, mouse
anti–human TfR was used at 1 
 

 
g/ml, mouse anti–human
ULBP3 was used at 0.66 
 

 
g/ml, mouse anti–human MICA was
used at 1.5 
 

 
g/ml, and mouse anti–human MHC class I (HC10;
American Type Culture Collection) was used at 1.5 
 

 
g/ml. Blots
were developed with chemiluminescent substrate (SuperSignal
 
®
 
;
Pierce Chemical Co.).
 
Analysis of Protein Acylation.
 
2 
 

 
 10
 
7
 
 Daudi/Class I
 

 
/MICA
(per IP) were resuspended in 2 ml RPMI 1640 culture medium
supplemented with 5% dialysed FBS and 10 mM sodium pyruvate
and subsequently labeled with 400 
 

 
Ci (9,10-[
 
3
 
H]
 
N
 
)palmitic acid
(40–60 Ci/mmol; Amersham Biosciences) and 100 
 

 
Ci [
 
35
 
S]me-
thionine (60 Ci/mmol; ICN Biomedicals) for 5 h at 37
 
	
 
C. Cells
were lysed in 1 ml RIPA buffer containing 0.1 mM PMSF and
protease inhibitors as described previously (20). DNA was sheared
by passage through a narrow-gauge syringe needle, debris was pel-
leted in a microfuge at 4
 
	
 
C, and 2 
 

 
g of each of the primary mAb
was added to the supernatant. After overnight incubation at 4
 
	
 
C
immunocomplexes were recovered on protein G-Sepharose (Am-
ersham Biosciences), washed, released from the beads with 25 
 

 
l
Laemmli gel sample buffer, and heated to 90
 
	
 
C for 3 min. Radio-
labeled proteins were analyzed by SDS-PAGE on 10% acrylamide
minigels under nonreducing conditions and visualized by fluorog-
raphy using Kodak X-Omat AR films as described previously (20).
 
NK Cell Cytotoxicity Assays.
 
The susceptibility of various tar-
get cells NK cytotoxicity was assessed in 5-h [
 
35
 
S]Met release as-
r
Σ gi g–( ) ri r–( )
Σ gi g–( )2 Σ ri r–( )2
--------------------------------------------------- ,=
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says performed in triplicate as described previously (19). Sponta-
neous release of 
 
35
 
S was 
 

 
20% of the maximal release.
 
Electron Microscopy.
 
Daudi transfectants were fixed with 2%
paraformaldehyde/PBS for 30 min at RT. Cells were washed in
PBS, and excess aldehyde was quenched using 50 mM glycine/
PBS. Cells were embedded in 12% gelatin in PBS and incubated
in 2.3 M sucrose at 4
 
	
 
C overnight. Blocks were mounted and
frozen in liquid nitrogen. Ultrathin sections were cut (Ultracut
FCS; Leica) and picked up in a 1:1 mixture of 2% methylcellulose
and 2.3 M sucrose. Sections were labeled with mAb in 1% BSA/
0.5% BSA-C (Aurion) as a blocking agent. This was followed by
rabbit anti–mouse bridging antibody (DakoCytomation), which
was detected using 10-nm gold particles conjugated to protein A
(obtained from J.W. Slot, Utrecht University, Utrecht, Nether-
lands). Sections were contrast stained and supported in a mixture
of methylcellulose and uranyl acetate before being imaged
(EM400; Phillips).
 
Results and Discussion
 
Colocalization of ULBP1, 2, and 3 and MICA with Cross-
linked Lipid Rafts.
 
To study the distribution of ULBP1, 2,
and 3 and MICA with respect to lipid rafts on Daudi/Class I
 

 
transfectants, we cross-linked the lipid raft resident GM1 gan-
glioside with CT-B to create distinct patches visible by fluo-
rescence microscopy (Fig. 1 a). After patching, the cells were
fixed and stained to show the distribution of NKG2D ligands.
As negative controls, we looked at the distribution of CD45
and TfR that do not accumulate in GM1 patches. Strikingly,
the majority of ULBP and MICA staining (Fig. 1 a, red) ac-
cumulated at the same areas on the cell surface as the GM1
patches (Fig. 1 a, green), whereas CD45 remained even
around the plasma membrane.
We developed software to calculate the correlation coef-
ficient between the intensity corresponding to CT-B and
each of the NKG2D ligands, similar to a method described
previously (21). A practical upper limit of the calculated
correlation coefficient was obtained by targeting anti–
CT-B with two different secondary antibodies. The distri-
bution of calculated correlation coefficients was quite broad.
Nevertheless, our analysis shows clearly that ULBP and
MICA colocalize within the GM1 patches (Fig. 1 b). Thus,
ULBP and MICA are preferentially concentrated in gly-
cosphingolipid-rich lipid rafts.
 
ULBP3 But Not MICA Associates with DRMs.
 
GPI-
linked proteins have a propensity for robust association
with biochemically isolated DRMs as a result of their Tri-
ton X-100 insolubility at 4
 
	
 
C and their low density (22). At
the same time, other membrane proteins, such as TfR, do
not copurify with DRMs (23, 24). Thus, we set out to
investigate whether ULBP3 and MICA associate with
DRMs; the mAbs for ULBP1 and ULBP2 were found to
be unsuitable for Western blotting.
DRMs were isolated by fractionating cell lysates and an-
alyzed by Western blotting. HRP-conjugated CT-B dem-
onstrated that GM1 ganglioside accumulated in DRMs as
expected (Fig. 2, a and b). Western blotting revealed that
ULBP3 accumulated in the DRM fractions from both
Daudi/Class I
 

 
/ULBP3 transfectants and Namalwa, a B
cell line endogenously expressing ULBP3 (Fig. 2 a). Thus,
ULBP3 is constitutively associated with DRMs.
MICA was absent from the DRM fractions as were TfR
and MHC class I proteins (Fig. 2 b). Thus, although MICA
clearly is expressed in particular membrane microdomains
(Fig. 1), it may have a weaker association to lipid rafts that
is not detected by the stringent technique used to isolate
DRMs. This is reminiscent of T cell receptor colocalizing
Figure 1. NKG2D ligands colocalize with cross-linked patches of
CT-B in Daudi transfectants. (a) After cross-linking GM1, Daudi/Class I
cells transfected with ULBP1, 2, 3, or MICA were fixed and stained for
CT-B (second column) and the appropriate NKG2D ligand (third column).
As a control, the distribution of CD45 was compared (last row). Images
show single confocal planes. Bars, 5 m. (b) Correlation coefficients
calculated for colocalization of CT-B and NKG2D ligands in individual
GM1-patched cells are shown (open circles). Filled circles mark the specific
cell shown in panel a. Between 14 and 27 cells of each type that had
clearly visible patching of GM1 were selected for quantitative analysis.
The mean for each cell type is shown with standard errors. The positive
control (Ctrl) corresponds to labeling of CT-B with two different
secondary antibodies.
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with patches of cell surface GM1, yet not routinely in bio-
chemically isolated DRMs (25).
It may be important to note that Western blotting of gels
in reducing conditions identified MICA with an apparent
molecular weight approximately twice that predicted by its
amino acid sequence. By cleaving N-linked oligosaccha-
rides in lysates of cells expressing MICA, a band corre-
sponding to a molecular mass of 45 kD can be detected
by Western blotting (unpublished data). Thus the high ap-
parent molecular weight of MICA in Fig. 2 b is likely due
to extensive glycosylation.
Electron Microscopy Reveals Clusters of ULBP at the Cell
Surface. For immunoelectron microscopy, cells were fixed
rapidly at 5	C, cryoprotected, and snap frozen in liquid ni-
trogen; therefore, movement and redistribution during
subsequent labeling procedures should not occur. CD45
was distributed evenly over the cell surface (Fig. 2 c).
However, immunogold labels for ULBP1 tended to con-
centrate in distinct clusters of 2–5 particles (Fig. 2 d). The
cell surface between these clusters was free of label, sug-
gesting that ULBP1 is expressed in distinct “islands” within
the plasma membrane. ULBP-rich membrane domains
spanned 30–100 nm, which is consistent with estimates
of the size of lipid rafts. Similar observations were seen for
ULBP3 (unpublished data). This suggests that ULBPs are
constitutively expressed in lipid rafts, and not just upon
cross-linking GM1 as shown in Fig. 1.
Accumulation of ULBP3, MICA, and Target Cell Lipid
Rafts at the Activating NK Cell Immune Synapse. To assess
the distribution of NKG2D ligands at human NK cell im-
mune synapses (26), NK cells were coincubated with
Daudi/Class I/MICA for 15 min before conjugates were
fixed and stained. The peripheral blood NK cell line effi-
ciently lysed Daudi/Class I/MICA (unpublished data).
MICA was found to accumulate at 50% of intercellular
contacts (n  301; Fig. 3 a) and was even seen to accumu-
late at two immune synapses formed by a single NK cell
(Fig. 3 a, first row). Thus, MICA accumulates at activating
NK cell immune synapses.
To assess the role of target cell lipid rafts at the activating
NK cell immune synapse, we transfected Namalwa with a
construct encoding GPI-anchored GFP (GPI-GFP). West-
ern blotting of DRMs confirmed that this transfectant ex-
pressed GFP in the GM1-rich membrane compartment
(unpublished data). We imaged conjugates formed between
this transfectant and an NK clone that efficiently lysed Na-
malwa. Fig. 3 b clearly demonstrates the simultaneous ac-
cumulation of ULBP3 and GPI-GFP (i.e., target cell lipid
rafts) at the activating NK cell immune synapse.
Due to the lower level of expression of ULBP3 in this
cell line compared with the Daudi transfectants, it was diffi-
cult to image ULBP3 at these synapses. Nevertheless, even
though we could clearly see accumulation of ULBP3 at the
immune synapse in only 25% of conjugates, in nearly all of
these cases (13 out of 14), GPI-GFP simultaneously accu-
mulated at the synapse. Thus, these data provide the first
evidence that target cell lipid rafts containing NKG2D
ligands are important in NK cell activation.
MICA Is S-acylated. Many proteins that associate with
lipid rafts are attached to saturated lipid groups likely to
Figure 2. Probing the cell surface organization of
NKG2D ligands in DRMs and by electron microscopy.
DRMs were prepared from (a) Daudi/Class I/ULBP3
and Namalwa or (b) Daudi/Class I/MICA cells. 10
fractions were collected from the top of the gradient
(fraction 1 denotes the top of the gradient and fraction
10 denotes the bottom), and equal volumes of each
were resolved by reducing electrophoresis and probed
by Western blotting for each molecule indicated.
DRM and detergent-soluble (Det. Sol.) fractions are
marked. Molecular masses are indicated in kilodaltons.
For TfR, a fainter second band corresponding to the
size of TfR dimers was also evident (not depicted).
ULPB3, but not MICA, associates with DRMs. Ultrathin
cryosections of Daudi/Class I/ULBP1 were immuno-
labeled for (c) CD45 or (d) ULBP1. Primary antibodies
were detected with 10 nm of gold particles conjugated
to protein A. ULBP1 is expressed in clusters at the cell
surface (arrowheads), as highlighted by the enlarged
view of a small region of cell surface (inset, bottom
right). Bar, 0.2 m.
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prefer the ordered environment of rafts. S-acylated pro-
teins are often targeted to lipid rafts; however, one excep-
tion is TfR. Thus, we set out to determine if MICA is
lipid modified. The fact that MICA contains a dicysteine
motif at positions 331 and 332 juxtaposed to its putative
transmembrane sequence suggested that the protein might
be S-acylated. To test this, MICA was immunoprecipi-
tated from lysates of cells preincubated with radiolabeled
palmitic acid. Immunoprecipitated MICA was radiola-
beled, demonstrating that MICA is indeed S-acylated
(Fig. 4 a).
A Truncated Form of MICA Is Unable to Activate NK
Cells. Toward demonstrating functional significance for
the transmembrane and/or cytoplasmic portions of MICA,
we generated a transfectant of Daudi expressing a truncated
form of MICA in which the cysteine at position 331 was
replaced with a stop codon (Daudi/Class I/MICA/
C331*). The level of cell surface staining of this transfectant
with a MICA mAb was similar to that of wild-type MICA
in Daudi/Class I/MICA (Fig. 4, b and c). We tested the
susceptibility of these transfectants to NK cell cytotoxicity
(Fig. 4 d). A peripheral blood NK cell line was efficiently
able to kill untransfected Daudi, which lacks endogenous
expression of MHC class I protein, but was inhibited from
killing Daudi-expressing MHC class I protein (Daudi/Class
I). In agreement with previous data (5), Daudi-expressing
MHC class I protein and MICA was efficiently killed,
demonstrating how activation via NKG2D recognition can
overcome inhibitory signaling. However, Daudi transfec-
tants expressing MHC class I protein and the truncated
form of MICA were not efficiently killed. Thus, removal
of the putative site of S-acylation and the cytoplasmic tail
of MICA abrogates cytolysis by human NK cells. From this
first study, it is possible that either S-acylation or another,
currently unknown, function of the cytoplasmic portion of
MICA could account for the loss of function of the trun-
cated MICA. Thus, we are currently establishing and test-
ing the effect of numerous point mutations in MICA to
determine precisely which amino acid residues control the
localization and function of MICA.
Figure 3. Recruitment of ULBP3 and MICA to the NK cell immune
synapse. (a) CD56 CD3
 human peripheral blood NK cells were coin-
cubated with Daudi/Class I/MICA cells for 15 min, fixed, and stained
with anti-MICA mAb, and the distribution at the immunological synapse
was determined. The first row shows a single NK cell forming two activating
synapses with two different Daudi/Class I/MICA cells. Data shown are
representative of three experiments in which 301 NK-Daudi/Class I/
MICA conjugates were assessed. (b) A CD56 CD3
 human peripheral
blood NK clone was coincubated with GPI-GFP–expressing Namalwa
transfectants for 15 min, fixed, and stained for ULBP3. Images are representa-
tive of 13 out of 14 conjugates where ULBP3 was clearly seen to accumulate
at the synapse. Bars, 5 m.
Figure 4. MICA is S-acylated, and a truncated form of MICA is unable
to activate NK cells. (a) Daudi/Class I/MICA cells were labeled for 5 h
with either [35S]methionine (35S MET) or with [3H]palmitate (3H PAL),
lysed, immunoprecipitated with anti-MICA or anti-TfR mAb, and analyzed
by SDS-PAGE and fluorography. Molecular weight markers (MW) are
also shown. The two bands seen for TfR correspond to the size of TfR
monomers and dimers. The mobility of MICA was higher in this gel than
in that used in Fig. 2, probably due to the nonreducing conditions. Fluoro-
grams were exposed for 81 d (3H PAL) or 7 d (35S MET). (b and c) Cell
surface staining by anti-MICA mAb of (b) Daudi/Class I/MICA and (c)
Daudi/Class I/MICA/C331*. Plots show staining with an isotype-
matched control mAb (shaded) and staining with anti-MICA (line).
(d) Susceptibility of Daudi (), Daudi/Class I (), Daudi/Class I/
MICA (), and Daudi/Class I/MICA/C331* () by a peripheral blood
NK cell line, assessed in a 5-h [35S]Met release assay. Data are representative
of three independent experiments, each performed in triplicate.
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In summary, we demonstrated by fluorescence imaging,
Western blotting of DRMs, and electron microscopy that
the stress-inducible ligands ULBP1, 2, 3, and MICA are ex-
pressed in specific membrane microdomains (Figs. 1 and 2).
In addition, we show that these proteins accumulate at acti-
vating NK cell immune synapses (Fig. 3). The molecular
mechanism by which these proteins are organized at the cell
surface likely involves attachment to specific lipids, which
may be important in triggering NK immune responses (Fig.
4). It has been demonstrated previously that viruses can pre-
vent cell surface expression of NKG2D ligands to evade NK
cell activation. In light of our analysis, it might be interest-
ing to investigate if some viruses or tumors have evolved
mechanisms to subvert NK activation by disrupting the cell
surface organization of NKG2D ligands.
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